Prevention of Recurrent Symptomatic Urinary Tract Infections in Patients with Chronic Neurogenic Bladder Dysfunction: A mixed Method Study (The PReSUTINeB Study).
Active, no longer recruiting
Phase of Trial: Phase III/IV
Latest Information Update: 04 Mar 2017
At a glance
- Drugs Escherichia-coli-strains (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- Acronyms The PReSUTINeB Study
- 11 May 2016 Status changed from not yet recruiting to recruiting.
- 14 Mar 2016 New trial record